Cite
Clark GM, McDonald AM, Nabors LB, et al. Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neurooncol Pract. 2014;1(4):172-177doi: 10.1093/nop/npu028.
Clark, G. M., McDonald, A. M., Nabors, L. B., Fathalla-Shaykh, H., Han, X., Willey, C. D., Markert, J. M., Guthrie, B. L., Bredel, M., & Fiveash, J. B. (2014). Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neuro-oncology practice, 1(4), 172-177. https://doi.org/10.1093/nop/npu028
Clark, Grant M, et al. "Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience." Neuro-oncology practice vol. 1,4 (2014): 172-177. doi: https://doi.org/10.1093/nop/npu028
Clark GM, McDonald AM, Nabors LB, Fathalla-Shaykh H, Han X, Willey CD, Markert JM, Guthrie BL, Bredel M, Fiveash JB. Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neurooncol Pract. 2014 Dec;1(4):172-177. doi: 10.1093/nop/npu028. PMID: 26034629; PMCID: PMC4369713.
Copy
Download .nbib